Table 1.
Clinical characteristics of RHTN groups
| cDM(n = 98) | ucDM(n = 122) | |
|---|---|---|
| Age, y | 57.52 ± 11.18 | 59.75 ± 10.42 |
| Female sex, % | 65 | 68 |
| BMI, kg/m² | 30.08 ± 4.60 | 31.70 ± 4.48* |
| ABPM SBP, mm Hg | 151.0 ± 20.1 | 151.1 ± 14.14 |
| ABPM DBP, mm Hg | 89.06 ± 12.18 | 87.72 ± 10.92 |
| ABPM PP, mm Hg | 62.20 ± 16.77 | 63.42 ± 14.32 |
| Glycated hemoglobin, % | 6.13 ± 0.35 | 8.08 ± 0.96≠ |
| Duration of RHTN + DM | 6.42 ± 3.94 | 7.44 ± 4.71 |
| Office SBP, mm Hg | 162.2 ± 17.9 | 153.6. ± 13.7 |
| Office DBP, mm Hg | 89.1 ± 21.1 | 87.2 ± 11.2 |
| Heart rate, beats per min | 71.2 ± 10.6 | 72.1 ± 12.1 |
| Total cholesterol, mg/dL | 204.61 ± 43.11 | 202.92 ± 43.11 |
| Current smokers, % | 5 | 9 |
Data are expressed as mean ± standard deviation. ABPM, ambulatory blood pressure monitoring; BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; PP, pulse pressure; RHTN, resistant hypertension; SBP, systolic blood pressure; ucDM, uncontrolled diabetes mellitus. *P = .0095 vs controlled diabetes mellitus (cDM). ≠ P < .0001 vs cDM.